We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+0.6%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$768M
AUM Growth
+$145M
Cap. Flow
-$380M
Cap. Flow %
-49.45%
Top 10 Hldgs %
72.07%
Holding
132
New
51
Increased
25
Reduced
6
Closed
37

Top Buys

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$14.4M
2
DYNC
Vistra Energy Corp.
DYNC
+$4.34M
3
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$1.78M
4
INSM icon
Insmed
INSM
+$1.65M
5
AWH
Allied World Assurance Co Hld Lt
AWH
+$823K

Top Sells

Rank Stock Value
1
ACOR
Acorda Therapeutics
ACOR
+$5.92M
2
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$4.78M
3
MU icon
Micron Technology
MU
+$4.25M
4
BEAV
B/E Aerospace Inc
BEAV
+$898K
5
WWAV
The WhiteWave Foods Company
WWAV
+$657K

Sector Composition

Rank Sector Weight
1 Miscellaneous 95.68%
2 Technology 2.11%
3 Healthcare 0.84%
4 Financials 0.33%
5 Consumer Staples 0.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANET icon
1
PUT
Arista Networks
ANET
$246B
$28.4M 3.7%
+3,032,000
New +$27.5M
SAGE
2
CALL
DELISTED
Sage Therapeutics
SAGE
$24.4M 3.18%
307,000
+61,200
+25% +$4.42M
SIOX
3
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$18.7M 2.44%
100,950
+35,112
+53% +$6.15M
ANET icon
4
Arista Networks
ANET
$246B
$14.9M 1.94%
+1,588,832
New +$14.4M
NXPI icon
5
PUT
NXP Semiconductors
NXPI
$56.4B
$13.2M 1.72%
+120,600
New +$12.9M
ZYNE
6
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$8.25M 1.07%
485,900
+337,500
+227% +$6.71M
DBVT
7
CALL
DBV Technologies
DBVT
$851M
$8.23M 1.07%
23,030
+10,420
+83% +$3.56M
INTC icon
8
PUT
Intel
INTC
$473B
$6.75M 0.88%
+200,000
New +$7.16M
ZYNE
9
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$6.19M 0.81%
364,300
+261,900
+256% +$5.21M
ANIP icon
10
PUT
ANI Pharmaceuticals
ANIP
$1.67B
$6.08M 0.79%
130,000
-46,000
-26% -$2.22M
NXPI icon
11
CALL
NXP Semiconductors
NXPI
$56.4B
$5.8M 0.75%
53,000
-125,400
-70% -$13.4M
OTIC
12
CALL
DELISTED
Otonomy, Inc.
OTIC
$5.79M 0.75%
+307,500
New +$4.29M
INSM icon
13
PUT
Insmed
INSM
$25.9B
$5.06M 0.66%
295,000
-35,400
-11% -$605K
DYNC
14
DELISTED
Vistra Energy Corp.
DYNC
$4.58M 0.6%
+75,000
New +$4.34M
HWM icon
15
PUT
Howmet Aerospace
HWM
$106B
$4.53M 0.59%
+260,800
New +$5.31M
MNK
16
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$4.48M 0.58%
+100,000
New +$4.39M
IMMU
17
CALL
DELISTED
Immunomedics Inc
IMMU
$4.08M 0.53%
461,200
+354,000
+330% +$2.49M
TTPH
18
PUT
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$4.06M 0.53%
+28,500
New +$4.4M
IMMU
19
PUT
DELISTED
Immunomedics Inc
IMMU
$3.95M 0.51%
+447,200
New +$3.14M
TVRD
20
PUT
Tvardi Therapeutics
TVRD
$24.3M
$3.46M 0.45%
+6,250
New +$3.97M
ARAV
21
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
$3.03M 0.39%
28,983
+10,750
+59% +$1.15M
VGR
22
PUT
DELISTED
Vector Group Ltd.
VGR
$2.98M 0.39%
228,515
+197,502
+637% +$2.6M
ZGNX
23
PUT
DELISTED
Zogenix, Inc.
ZGNX
$2.92M 0.38%
+201,500
New +$2.53M
PALI icon
24
CALL
Palisade Bio
PALI
$349M
$2.1M 0.27%
+4
New +$1.75M
INSM icon
25
Insmed
INSM
$25.9B
$1.66M 0.22%
+96,730
New +$1.65M
1
2 3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return

DLD Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, DLD Asset Management held 132 positions worth $768M, up 23% from $623M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

DLD Asset Management withdrew a net $380M in Q2 2017, closing 37 positions and reducing 6 holdings. Its most notable exit was Acorda Therapeutics, an estimated $5.92M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, up from 96% a quarter earlier, followed by Technology and Healthcare.

Against the trend, DLD Asset Management opened a new position in Arista Networks worth $14.9M.

  • DLD Asset Management's largest Q2 2017 buy was Arista Networks: 1,588,832 shares worth $14.9M.
  • DLD Asset Management added most to Level 3 Communications Inc in Q2 2017, an estimated $759K increase.
  • DLD Asset Management fully exited Acorda Therapeutics in Q2 2017, selling an estimated $5.92M.
  • DLD Asset Management's ten largest holdings make up 72% of its $768M portfolio in Q2 2017.
  • DLD Asset Management opened 51 new positions and closed 37 in Q2 2017.
  • DLD Asset Management's portfolio value rose 23% quarter-over-quarter to $768M.

Based on DLD Asset Management's 13F filing for Q2 2017, filed 11 Aug 2017.